These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1953510)

  • 1. Standardised initial warfarin treatment: evaluation of initial treatment response and maintenance dose prediction by randomised trial, and risk factors for an excessive warfarin response.
    Doecke CJ; Cosh DG; Gallus AS
    Aust N Z J Med; 1991 Jun; 21(3):319-24. PubMed ID: 1953510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen.
    Siguret V; Gouin I; Debray M; Perret-Guillaume C; Boddaert J; Mahé I; Donval V; Seux ML; Romain-Pilotaz M; Gisselbrecht M; Verny M; Pautas E
    Am J Med; 2005 Feb; 118(2):137-42. PubMed ID: 15694897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting.
    Sridhar VS; Leung P; Seymour N; Nagge J
    Can Fam Physician; 2014 Nov; 60(11):e535-40. PubMed ID: 25551135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?
    Le Gal G; Carrier M; Tierney S; Majeed H; Rodger M; Wells PS
    J Thromb Haemost; 2010 Jan; 8(1):90-4. PubMed ID: 19874475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetaminophen and other risk factors for excessive warfarin anticoagulation.
    Hylek EM; Heiman H; Skates SJ; Sheehan MA; Singer DE
    JAMA; 1998 Mar; 279(9):657-62. PubMed ID: 9496982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of initial warfarin dosing based on simple clinical criteria.
    Shine D; Patel J; Kumar J; Malik A; Jaeger J; Maida M; Ord L; Burrows G
    Thromb Haemost; 2003 Feb; 89(2):297-304. PubMed ID: 12574810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new regimen for starting warfarin therapy in out-patients.
    Oates A; Jackson PR; Austin CA; Channer KS
    Br J Clin Pharmacol; 1998 Aug; 46(2):157-61. PubMed ID: 9723825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the warfarin maintenance dose in elderly inpatients at treatment initiation: accuracy of dosing algorithms incorporating or not VKORC1/CYP2C9 genotypes.
    Moreau C; Pautas E; Gouin-Thibault I; Golmard JL; Mahé I; Mulot C; Loriot MA; Siguret V
    J Thromb Haemost; 2011 Apr; 9(4):711-8. PubMed ID: 21255252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of a flexible protocol for starting treatment with warfarin and predicting its maintenance dose.
    Cosh DG; Moritz CK; Ashman KJ; Dally RJ; Gallus AS
    Aust N Z J Med; 1989 Jun; 19(3):191-7. PubMed ID: 2775039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.
    Hylek EM; Regan S; Go AS; Hughes RA; Singer DE; Skates SJ
    Ann Intern Med; 2001 Sep; 135(6):393-400. PubMed ID: 11560452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
    Ripley TL; Harrison D; Germany RE; Adamson PB
    Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of an age-adjusted warfarin initiation protocol.
    Roberts GW; Helboe T; Nielsen CB; Gallus AS; Jensen I; Cosh DG; Eaton VS
    Ann Pharmacother; 2003 Jun; 37(6):799-803. PubMed ID: 12773064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial.
    Lancet; 1996 Sep; 348(9028):633-8. PubMed ID: 8782752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
    Schultz KT; Bungard TJ
    Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuation.
    Pengo V; Banzato A; Garelli E; Zasso A; Biasiolo A
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):739-41. PubMed ID: 8292723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter evaluation of six methods for predicting warfarin maintenance-dose requirements from initial response.
    Sawyer WT; Poe TE; Canaday BR; Weiner JS; Williams DM; Webb CE; Ellison MJ
    Clin Pharm; 1985; 4(4):440-6. PubMed ID: 3899472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement.
    Ageno W; Turpie AG; Steidl L; Ambrosini F; Cattaneo R; Codari RL; Nardo B; Venco A
    Am J Cardiol; 2001 Jul; 88(1):40-4. PubMed ID: 11423056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial.
    Schulman S; Hwang HG; Eikelboom JW; Kearon C; Pai M; Delaney J
    J Thromb Haemost; 2014 Aug; 12(8):1254-9. PubMed ID: 24837794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.
    Hylek EM; Chang YC; Skates SJ; Hughes RA; Singer DE
    Arch Intern Med; 2000 Jun; 160(11):1612-7. PubMed ID: 10847254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for excessive anticoagulation among hospitalized adults receiving warfarin therapy using a pharmacist-managed dosing protocol.
    Berg TM; O'Meara JG; Ou NN; Daniels PR; Moriarty JP; Bergstrahl EJ; Dierkhising RA; Manning DM
    Pharmacotherapy; 2013 Nov; 33(11):1165-74. PubMed ID: 23625787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.